Reduction of serum FABP4 level by sitagliptin, a DPP-4 inhibitor, in patients with type 2 diabetes mellitus

Fatty acid binding protein 4 (FABP4), also known as adipocyte FABP or aP2, is secreted from adipocytes in association with lipolysis as a novel adipokine, and elevated serum FABP4 level is associated with obesity, insulin resistance, and atherosclerosis. However, little is known about the modulation...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:J Lipid Res
Päätekijät: Furuhashi, Masato, Hiramitsu, Shinya, Mita, Tomohiro, Fuseya, Takahiro, Ishimura, Shutaro, Omori, Akina, Matsumoto, Megumi, Watanabe, Yuki, Hoshina, Kyoko, Tanaka, Marenao, Moniwa, Norihito, Yoshida, Hideaki, Ishii, Junnichi, Miura, Tetsuji
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: The American Society for Biochemistry and Molecular Biology 2015
Aiheet:
Patient-Oriented and Epidemiological Research
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC4655983/
https://ncbi.nlm.nih.gov/pubmed/26467280
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1194/jlr.M059469
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia